| | | 00646 | | 10.08.2000 | | Sanofi-Aventis (Suisse) SA | | | | | | | | | | | | | 08.08. | | | | 08.08. | | IP |
| | Seq.-No. | Product | Description | Galenic form | ATC-classification | |
|---|
| 01 | Revaxis | suspension injectable | Injection suspension (Toxoidum Tetani 20U.I. / 0.5ml, Toxoidum Diphtheriae 2U.I. / 0.5ml) | J07CA01 | | | 02 | Revaxis | | (Vaccinum Tetani Adsorbatum 0 , Vaccinum Diphtheriae Adsorbatum 0 , Vaccinum Poliomyelitidis Inactivatum (Salk typ I, II, III) 0 ) | Codice | | | 03 | Revaxis | | (Toxoidum Tetani 20 UI, Toxoidum Diphtheriae 2 UI, Vaccinum Poliomyelitidis Inactivatum (Salk typ I, II, III) 62 U) | | |
|
|
